Talk Bio

Rare Disease Drugmakers Watch FDA for Renewed Focus on Therapies

FDA Accelerates Rare Disease Drug Approvals with New Frameworks and Record 2025 Approvals

FDA Releases Draft Guidance on Plausible Mechanism Framework for Individualized Therapies in Ultra-Rare Diseases